Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioblastoma × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Pain, Postoperative 17 Neoplasms 13 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Lung Neoplasms 12 Brain Neoplasms 10 Prostatic Neoplasms 9 Ovarian Neoplasms 9 Colorectal Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma, Hepatocellular 7 Depression 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Pain 4 Multiple Myeloma 4 Lymphoma 4 Leiomyoma 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Myofibroma 3 Lymphoma, Non-Hodgkin 3

Interventions

Temozolomide 373 Radiotherapy 187 Bevacizumab 143 Radiation 73 Magnetic Resonance Spectroscopy 67 Lomustine 45 pembrolizumab 38 Surgical Procedures, Operative 37 Irinotecan 37 Carmustine 37 Nivolumab 27 Carboplatin 25 Specimen Handling 24 Radiosurgery 23 Erlotinib Hydrochloride 23 Radiotherapy, Intensity-Modulated 20 Chemotherapy, Adjuvant 20 Aminolevulinic Acid 19 Cyclophosphamide 18 Drug Therapy 17 sargramostim 16 O(6)-benzylguanine 14 Radiotherapy, Conformal 13 Granulocyte-Macrophage Colony-Stimulating Factor 13 Blood Specimen Collection 13 Everolimus 12 temsirolimus 11 Vorinostat 11 Sunitinib 11 Imatinib Mesylate 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed

175 enrolled 18 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡